{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T10:22:15Z","timestamp":1787739735913,"version":"build-2784847793"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T00:00:00Z","timestamp":1660003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T00:00:00Z","timestamp":1660003200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002839","name":"Charit\u00e9 - Universit\u00e4tsmedizin Berlin","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002839","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologie"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s00347-022-01696-2","type":"journal-article","created":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T06:02:35Z","timestamp":1660024955000},"page":"98-101","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["R\u00e4tselhafte bilaterale Aderhautpigmentierungen","Mysterious bilateral choroidal pigmentation"],"prefix":"10.1007","volume":"120","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7062-4319","authenticated-orcid":false,"given":"Sophie-I.","family":"Anders","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Zeitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"B\u00f6ker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia M.","family":"Joussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,9]]},"reference":[{"key":"1696_CR1","doi-asserted-by":"publisher","DOI":"10.1097\/ICB.0000000000000429","author":"R Dolz-Marco","year":"2017","unstructured":"Dolz-Marco\u00a0R, Vilaplana\u00a0F, Gallego-Pinazo\u00a0R, Freund\u00a0KB (2017) Delayed-onset bilateral diffuse uveal melanocytic proliferation associated with gastric adenocarcinoma. Retina Cases Br Rep. https:\/\/doi.org\/10.1097\/ICB.0000000000000429","journal-title":"Retina Cases Br Rep"},{"key":"1696_CR2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1990.01070060075053","author":"JDM Gass","year":"1990","unstructured":"Gass\u00a0JDM, Gieser\u00a0RG, Wilkinson\u00a0CP et\u00a0al (1990) Bilateral diffuse uveal melanocytic proliferation in patients with occult carcinoma. Arch Ophthalmol. https:\/\/doi.org\/10.1001\/archopht.1990.01070060075053","journal-title":"Arch Ophthalmol"},{"key":"1696_CR3","doi-asserted-by":"publisher","DOI":"10.1111\/aos.13481","author":"K Klemp","year":"2017","unstructured":"Klemp\u00a0K, Kiilgaard\u00a0JF, Heegaard\u00a0S et\u00a0al (2017) Bilateral diffuse uveal melanocytic proliferation: case report and literature review. Acta Ophthalmol. https:\/\/doi.org\/10.1111\/aos.13481","journal-title":"Acta Ophthalmol"},{"key":"1696_CR4","doi-asserted-by":"publisher","DOI":"10.17219\/acem\/73860","author":"M Kordys","year":"2018","unstructured":"Kordys\u00a0M, Przezdziecka-Do\u0142yk\u00a0J, Turno-Krecicka\u00a0A, Misiuk-Hoj\u0142o\u00a0M (2018) Immunopathogenesis of ophthalmological paraneoplastic syndromes: recent findings. Adv Clin Exp Med. https:\/\/doi.org\/10.17219\/acem\/73860","journal-title":"Adv Clin Exp Med"},{"key":"1696_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-020-01376-2","author":"M Luo","year":"2020","unstructured":"Luo\u00a0M, Chen\u00a0Z, Luo\u00a0Y et\u00a0al (2020) Diagnosis of bilateral diffuse uveal melanocytic proliferation unveils primary gastric adenocarcinoma: a case report. BMC Ophthalmol. https:\/\/doi.org\/10.1186\/s12886-020-01376-2","journal-title":"BMC Ophthalmol"}],"container-title":["Die Ophthalmologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-022-01696-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00347-022-01696-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-022-01696-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T17:52:47Z","timestamp":1674496367000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00347-022-01696-2"}},"subtitle":["Fall einer Patientin mit Visusverschlechterung und beidseitigen Aderhautpigmentierungen, die zur Entdeckung einer fortgeschrittenen Grunderkrankung f\u00fchrt","A case of a female patient with visual deterioration and bilateral choroidal pigmentation that leads to the discovery of an advanced underlying disease"],"short-title":[],"issued":{"date-parts":[[2022,8,9]]},"references-count":5,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["1696"],"URL":"https:\/\/doi.org\/10.1007\/s00347-022-01696-2","relation":{},"ISSN":["2731-720X","2731-7218"],"issn-type":[{"value":"2731-720X","type":"print"},{"value":"2731-7218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,9]]},"assertion":[{"value":"5 July 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"O.\u00a0Zeitz: Beratungshonorare: Allergan, Bayer, Novartis, Boehringer Ingelheim, Roche, Oxular, SamChungDan Pharma; Zahlungen oder Honorare f\u00fcr Vortr\u00e4ge, Pr\u00e4sentationen, Rednerb\u00fcros, Manuskriptschreiben oder Bildungsveranstaltungen: Allergan, Bayer, Novartis, Roche, Boehringer Ingelheim; Teilnahme an einem Data Safety Monitoring Board oder Advisory Board: Boehringer Ingelheim, SamChungDan Pharma. S.-I.\u00a0Anders, A.\u00a0B\u00f6ker und A.M.\u00a0Joussen geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patient\/innen zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern\/Vertreterinnen eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}